Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence

INTRODUCTION: Menopausal hormone therapy (HT) is typically withheld from breast cancer survivors because of concerns about risk for recurrence. Our objectives were to estimate the effects of HT on recurrence in breast cancer survivors and to examine the reliability of these estimates. METHODS: In a...

Descripción completa

Detalles Bibliográficos
Autores principales: Col, Nananda F, Kim, Jung A, Chlebowski, Rowan T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175064/
https://www.ncbi.nlm.nih.gov/pubmed/15987460
http://dx.doi.org/10.1186/bcr1035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175064/
https://www.ncbi.nlm.nih.gov/pubmed/15987460
http://dx.doi.org/10.1186/bcr1035

Ejemplares similares